Results: 1-25 | 26-27
Results: 1-25/27

Authors: SMITH JD MIYATA M POULIN SE NEVEUX LM CRAIG WY
Citation: Jd. Smith et al., THE RELATIONSHIP BETWEEN APOLIPOPROTEIN-E AND SERUM OXIDATION RELATEDVARIABLES IS APOLIPOPROTEIN-E PHENOTYPE DEPENDENT, International journal of clinical & laboratory research, 28(2), 1998, pp. 116-121

Authors: RITCHIE RF PALOMAKI GE NEVEUX LM NAVOLOTSKAIA O LEDUE TB CRAIG WY
Citation: Rf. Ritchie et al., REFERENCE DISTRIBUTIONS FOR IMMUNOGLOBULIN-A, IMMUNOGLOBULIN-G, AND IMMUNOGLOBULIN-M - A PRACTICAL, SIMPLE, AND CLINICALLY RELEVANT APPROACH IN A LARGE COHORT, Journal of clinical laboratory analysis, 12(6), 1998, pp. 363-370

Authors: ROSEN CJ KURLAND ES VEREAULT D ADLER RA RACKOFF PJ CRAIG WY WITTE S ROGERS J BILEZIKIAN JP
Citation: Cj. Rosen et al., ASSOCIATION BETWEEN SERUM-INSULIN GROWTH-FACTOR-I (IGF-I) AND A SIMPLE SEQUENCE REPEAT IN IGF-I GENE - IMPLICATIONS FOR GENETIC-STUDIES OF BONE-MINERAL DENSITY, The Journal of clinical endocrinology and metabolism, 83(7), 1998, pp. 2286-2290

Authors: CRAIG WY NEVEUX LM PALOMAKI GE CLEVELAND MM HADDOW JE
Citation: Wy. Craig et al., LIPOPROTEIN(A) AS A RISK FACTOR FOR ISCHEMIC-HEART-DISEASE - METAANALYSIS OF PROSPECTIVE STUDIES, Clinical chemistry, 44(11), 1998, pp. 2301-2306

Authors: ROSEN CJ VEREAULT DA RAYMOND JP HOFFMAN RM CRAIG WY
Citation: Cj. Rosen et al., INSULIN-LIKE GROWTH-FACTOR-I - A RISK FACTOR FOR RESTENOSIS AFTER CORONARY ANGIOPLASTY, Circulation, 96(8), 1997, pp. 3305-3305

Authors: LEDUE TB COLLINS MF CRAIG WY
Citation: Tb. Ledue et al., NEW LABORATORY GUIDELINES FOR SEROLOGIC DIAGNOSIS OF LYME-DISEASE - EVALUATION OF THE 2-TEST PROTOCOL, Journal of clinical microbiology, 34(10), 1996, pp. 2343-2350

Authors: CRAIG WY DAVIS AE POULIN SE
Citation: Wy. Craig et al., EFFECTS OF INCUBATION CONDITIONS ON ELISA FOR AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY-LIPOPROTEIN, Clinical chemistry, 42(10), 1996, pp. 1709-1711

Authors: CRAIG WY POULIN SE PALOMAKI GE NEVEUX LM RITCHIE RF LEDUE TB
Citation: Wy. Craig et al., OXIDATION-RELATED ANALYTES AND LIPID AND LIPOPROTEIN CONCENTRATIONS IN HEALTHY-SUBJECTS, Arteriosclerosis, thrombosis, and vascular biology, 15(6), 1995, pp. 733-739

Authors: CRAIG WY POULIN SE NEVEUX LM PALOMAKI GE DOSTALJOHNSON DA LEDUE TB RITCHIE RF
Citation: Wy. Craig et al., ANTI-OXIDIZED LDL ANTIBODIES AND ANTIPHOSPHOLIPID ANTIBODIES IN HEALTHY-SUBJECTS - RELATIONSHIP WITH LIPOPROTEIN-RELATED AND OXIDATION-RELATED ANALYTES, Journal of autoimmunity, 8(5), 1995, pp. 713-726

Authors: CRAIG WY
Citation: Wy. Craig, AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY-LIPOPROTEIN - A REVIEW OFCLINICAL FINDINGS AND ASSAY METHODOLOGY, Journal of clinical laboratory analysis, 9(1), 1995, pp. 70-74

Authors: CRAIG WY HADDOW JE
Citation: Wy. Craig et Je. Haddow, LIPOPROTEIN (A) LEVELS IN PERIPHERAL ATHEROSCLEROTIC DISEASE - REPLY, Journal of vascular surgery, 22(6), 1995, pp. 814-815

Authors: CRAIG WY KLOZA EM HADDOW JE HITCHCOCK JL ELDRUPJORGENSEN J
Citation: Wy. Craig et al., LIPOPROTEIN(A) LEVELS IN PERIPHERAL ATHEROSCLEROTIC DISEASE, Journal of vascular surgery, 21(3), 1995, pp. 541-542

Authors: BOSTOM AG HUME AL EATON CB LAURINO JP YANEK LR REGAN MS MCQUADE WH CRAIG WY PERRONE G JACQUES PF
Citation: Ag. Bostom et al., THE EFFECT OF HIGH-DOSE ASCORBATE SUPPLEMENTATION ON PLASMA LIPOPROTEIN(A) LEVELS IN PATIENTS WITH PREMATURE CORONARY HEART-DISEASE, Pharmacotherapy, 15(4), 1995, pp. 458-464

Authors: CRAIG WY BOSTOM AG
Citation: Wy. Craig et Ag. Bostom, LIPOPROTEIN(A) CONCENTRATION AND RISK OF ATHEROTHROMBOTIC DISEASE, JAMA, the journal of the American Medical Association, 274(15), 1995, pp. 1198-1198

Authors: LEDUE TB CRAIG WY
Citation: Tb. Ledue et Wy. Craig, SERUM CONCENTRATIONS OF TRANSFERRIN RECEPTOR IN HEREDITARY HEMOCHROMATOSIS, Clinical chemistry, 41(7), 1995, pp. 1053-1054

Authors: JOHNSON AM CRAIG WY LEDUE TB
Citation: Am. Johnson et al., CLINICAL USE OF APOLIPOPROTEIN QUANTITATION, Annals of internal medicine, 122(1), 1995, pp. 69-69

Authors: COOPER AD CRAIG WY TANIGUCHI T EVERSON GT
Citation: Ad. Cooper et al., CHARACTERISTICS AND REGULATION OF BILE-SALT SYNTHESIS AND SECRETION BY HUMAN HEPATOMA HEPG2 CELLS, Hepatology, 20(6), 1994, pp. 1522-1531

Authors: CRAIG WY LEDUE TB
Citation: Wy. Craig et Tb. Ledue, CHANGES IN SERUM ANTIBODIES TO OXIDIZED LOW-DENSITY-LIPOPROTEIN WITH AGE, Lancet, 344(8919), 1994, pp. 411-411

Authors: WALD NJ LAW M WATT HC WU TS BAILEY A JOHNSON AM CRAIG WY LEDUE TB HADDOW JE
Citation: Nj. Wald et al., APOLIPOPROTEINS AND ISCHEMIC-HEART-DISEASE - IMPLICATIONS FOR SCREENING, Lancet, 343(8889), 1994, pp. 75-79

Authors: LEDUE TB CRAIG WY COLLINS MF RITCHIE RF
Citation: Tb. Ledue et al., TECHNICAL ISSUES RELATED TO CHECKERBOARD IMMUNOBLOTTING, Journal of immunological methods, 176(2), 1994, pp. 275-277

Authors: LEDUE TB CRAIG WY RITCHIE RF HADDOW JE
Citation: Tb. Ledue et al., INFLUENCE OF BLOOD DONATION AND IRON SUPPLEMENTATION ON INDICATORS OFIRON STATUS, Clinical chemistry, 40(7), 1994, pp. 1345-1346

Authors: CRAIG WY POULIN SE NELSON CP RITCHIE RF
Citation: Wy. Craig et al., ELISA OF IGG ANTIBODY TO OXIDIZED LOW-DENSITY-LIPOPROTEIN - EFFECTS OF BLOCKING BUFFER AND METHOD OF DATA EXPRESSION, Clinical chemistry, 40(6), 1994, pp. 882-888

Authors: JOHNSON AM LEDUE TB PALOMAKI GE CRAIG WY
Citation: Am. Johnson et al., EFFECT OF STORAGE AT -70-DEGREES-C ON IMMUNOTURBIDIMETRIC ASSAYS FOR APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B, Clinica chimica acta, 231(1), 1994, pp. 89-94

Authors: CRAIG WY RITCHIE RF
Citation: Wy. Craig et Rf. Ritchie, LIPOPROTEIN(A) LEVELS IN THE NEPHROTIC SYNDROME, Annals of internal medicine, 120(2), 1994, pp. 165-166

Authors: CRAIG WY POULIN SE DORSETT PH LEDUE TB RITCHIE RF
Citation: Wy. Craig et al., APPLICATION OF CHECKERBOARD IMMUNOBLOTTING (CBIB) TO THE DETECTION OFANTIVIRAL IGG IN HUMAN SERUM, Journal of clinical laboratory analysis, 7(4), 1993, pp. 203-208
Risultati: 1-25 | 26-27